Amgen is now accepting submissions from promising Massachusetts start-up companies to compete for two highly sought-after Golden Tickets to LabCentral, which will set them up with lab space, amenities, and services at Cambridge’s premier life sciences launchpad as well as access to Amgen’s network of talent and expertise.
All companies with innovative advancements in the cardiovascular and metabolic diseases, oncology, or inflammation therapeutic areas are encouraged to apply, as well as are those focused on making groundbreaking advancements in AI, data science, and manufacturing innovation. Visit the 2020 Amgen-LabCentral Golden Ticket Competition website for full details and to submit your application by October 12, 2020. This is one of the final chances to secure a Golden Ticket to LabCentral in 2020—don’t miss your opportunity!
If you would like to submit an application, please
1) Apply at Amgen site: https://app.reviewr.com/s1/site/Amgen_LabCentralGoldenTicket20 and
2) Submit here and we'll try to to help you get status on your application.
In your response, please
Disclaimer: MIT Startup Exchange can make introductions that ideally provide open ended discussions in order to share mutual interests and potentially create common ground that incite the parties to collaborate. MIT Startup Exchange introductions may eventually lead to mutual partnerships, but that is not in any way guaranteed by MIT, MIT Corporate Relations, MIT Industrial Liaison Program (ILP) or MIT Startup Exchange, which takes no responsibility for these outcomes and no formal part in such discussions following our introduction. MIT Startup Exchange and its activities and events are not for purposes of soliciting investment or offering securities.